Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial

BACKGROUND: Dual antiplatelet therapy with aspirin and thienopyridine is required after placement of coronary drug-eluting stents (DES) to prevent thrombotic complications. Current clinical guidelines recommend at least 6 to 12 months of treatment after a DES implantation, but it may be beneficial t...

Descripción completa

Detalles Bibliográficos
Autores principales: Helft, Gérard, Le Feuvre, Claude, Georges, Jean Louis, Carrie, Didier, Leclercq, Florence, Eltchaninoff, Hélène, Furber, Alain, Prunier, Fabrice, Sebagh, Laurent, Cattan, Simon, Cayla, Guillaume, Vicaut, Eric, Metzger, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598827/
https://www.ncbi.nlm.nih.gov/pubmed/23433461
http://dx.doi.org/10.1186/1745-6215-14-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598827/
https://www.ncbi.nlm.nih.gov/pubmed/23433461
http://dx.doi.org/10.1186/1745-6215-14-56

Ejemplares similares